Home/Filings/4/0001437749-25-008653
4//SEC Filing

Cummings James F. 4

Accession 0001437749-25-008653

CIK 0000072444other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 9:43 PM ET

Size

14.9 KB

Accession

0001437749-25-008653

Insider Transaction Report

Form 4
Period: 2023-03-28
Cummings James F.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2025-03-18$0.57/sh6,772$3,861343,049 total
  • Tax Payment

    Common Stock

    2023-03-28$0.75/sh3,267$2,451349,821 total
Footnotes (4)
  • [F1]This transaction is being reported late due to administrative oversight.
  • [F2]Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 28, 2023.
  • [F3]Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2025.
  • [F4]Includes 75,618 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.

Issuer

Vaxart, Inc.

CIK 0000072444

Entity typeother

Related Parties

1
  • filerCIK 0001886760

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 9:43 PM ET
Size
14.9 KB